Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian share markets remain buoyant
Thu, 28 Nov 01:30 pm

After a firm opening, Indian share markets continued to trade well above the dotted line in the post-noon trading session. All the sectoral indices are trading in the green with realty, capital goods and power stocks being the biggest gainers.

BSE-Sensex is up 133 points and NSE-Nifty is trading 42 points up. BSE Mid Cap is trading up 0.8% and BSE Small Cap index is trading up 1%. The rupee is trading at 62.4 to the US dollar.

All the automobile stocks are trading in the green with Eicher Motors and Ashok Leyland being the major gainers. As per a leading financial daily, Ashok Leyland has launched intermediate commercial range of vehicle 'Boss' in Andhra Pradesh market. The new range will be launched across the country in a phased manner after operations are consolidated in the southern and western regions. Ashok Leyland wants to increase its presence in the rapidly growing intermediate range of commercial vehicles that have carrying capacity of 8 to 16 tonnes. Currently the company has a single offering in this segment and plans to acquire a bigger share through the launch of Boss for haulage in 9.6, 11.9 and 12.9 tonnes. The Boss range is manufactured in the company's Pantnagar facility in Uttarakhand. Ashok Leyland's stock is currently trading up by 3.2%.

Most of the Indian pharma stocks are trading in green with Indoco Remedies and Glenmark Pharmaceuticals witnessing maximum buying. Recently, Wockhardt Ltd announced that the company's second facility has also received import alert on its Chikalthana facility. It is important to note that company's key product Metropolol succinate was also manufactured in this facility. The ban on this product will be quite negative for the company. This was an important contributor to the company's US revenues. Company had around 20% market share in this product. There are just 4-5 players who have launched this product. By nature this product has high entry barriers and thus better margins. Among these 4-5 players, even <>Dr Reddy's sells the generics of this drug in the US market. It is likely that the ban on Wockhardt's facility might impact its market share with Dr Reddy's and other players expected to gain. In our view, Dr Reddy currently has 12% market share in Metropolol succinate and might gain some share from Wockhardt's exit.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Indian share markets remain buoyant". Click here!

  

Related Views on News

ASHOK LEYLAND Announces Quarterly Results (3QFY20); Net Profit Down 92.7% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, ASHOK LEYLAND has posted a net profit of Rs 278 m (down 92.7% YoY). Sales on the other hand came in at Rs 40 bn (down 36.5% YoY). Read on for a complete analysis of ASHOK LEYLAND's quarterly results.

ASHOK LEYLAND Announces Quarterly Results (2QFY20); Net Profit Down 91.5% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, ASHOK LEYLAND has posted a net profit of Rs 389 m (down 91.5% YoY). Sales on the other hand came in at Rs 39 bn (down 48.4% YoY). Read on for a complete analysis of ASHOK LEYLAND's quarterly results.

ASHOK LEYLAND 2018-19 Annual Report Analysis (Annual Result Update)

Sep 16, 2019 | Updated on Sep 16, 2019

Here's an analysis of the annual report of ASHOK LEYLAND for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ASHOK LEYLAND. Also includes updates on the valuation of ASHOK LEYLAND.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living (Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE AUTO


Feb 26, 2021 (Close)

S&P BSE AUTO 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS